Abstract
Regarding thromboembolic events, non-vitamin K antagonists, so-called new oral anticoagulative agents (NOACs), have widely enlarged prophylaxis and th......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
